Biotech Values

[ghmm]

Might Roche have wanted to get out of the exclusivity for more immediate reasons? Specifically I was wondering if they would consider some sort of marketing deal with Vertex where they push Pegasys instead of PEG-Intron... I still remain in the camp that Danoprevir's still alive .